C

Cerus Corp
D

CERS

2.02000
USD
-0.25
(-11.01%)
مغلق
حجم التداول
117,343
الربح لكل سهم
0
العائد الربحي
0
P/E
-12
حجم السوق
289,063,644
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AXGN
    -0.63000
    (-7.16%)
    8.17000 USD
    B
    BAX
    0.190
    (0.53%)
    36.000 USD
    BSX
    1.315
    (1.78%)
    75.170 USD
    E
    EXAS
    12.150
    (26.55%)
    57.910 USD
    ISRG
    6.98
    (1.57%)
    451.27 USD
    MDT
    0.160
    (0.20%)
    80.470 USD
    NVS
    0.650
    (0.58%)
    112.100 USD
    TMO
    9.03
    (1.47%)
    621.78 USD
    Z
    ZBH
    -0.280
    (-0.25%)
    111.100 USD
الأخبار
المقالات

العنوان: Cerus Corp

القطاع: Healthcare
الصناعة: Medical Devices
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.